Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncology, 2020 | 273 | 2020 |
Overexpression of Orphan Receptor Tyrosine Kinase Ror1 as a Putative Tumor-Associated Antigen in Iranian Patients with Acute Lymphoblastic Leukemia M Shabani, H Asgarian Omran, M Jeddi-Tehrani, P Vossough, ... Tumor Biology 28 (6), 318-326, 2008 | 59 | 2008 |
Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia M Shabani, H Asgarian-Omran, P Vossough, RA Sharifian, M Faranoush, ... Leukemia & lymphoma 49 (7), 1360-1367, 2008 | 59 | 2008 |
Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura E Shahgholi, P Vosough, K Sotoudeh, K Arjomandi, S Ansari, S Salehi, ... The Indian Journal of Pediatrics 75, 1231-1235, 2008 | 56 | 2008 |
The prognostic value of thrombocytopenia in COVID-19 patients; a systematic review and meta-analysis D Bashash, FS Hosseini-Baharanchi, M Rezaie-Tavirani, M Safa, ... Archives of academic emergency medicine 8 (1), 2020 | 47 | 2020 |
Endocrinopathies in patients with transfusion-dependent ß-thalassemia A Mehrvar, A Azarkeivan, M Faranoush, N Mehrvar, J Saberinedjad, ... Pediatric Hematology and Oncology 25 (3), 187-194, 2008 | 40 | 2008 |
Prevalence and Prognostic Impact of Wilms' Tumor 1 (WT1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic Leukemia (CN-AML): An Iranian Experience. C Toogeh G, Ramzi M, Faranoush M, Amirizadeh N, Haghpanah S, Moghadam M Clin Lymphoma Myeloma Leuk., 2015 | 39* | 2015 |
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries ID Fabian, E Abdallah, SU Abdullahi, RA Abdulqader, AA Abdulrahaman, ... The Lancet global health 10 (8), e1128-e1140, 2022 | 38 | 2022 |
Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi‐institutional international collaborative study (CALLME1) by the Middle … NA Al‐Mulla, P Chandra, M Khattab, F Madanat, P Vossough, E Torfa, ... Pediatric blood & cancer 61 (8), 1403-1410, 2014 | 37 | 2014 |
Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin F Alikarami, M Safa, M Faranoush, P Hayat, A Kazemi Biomedicine & Pharmacotherapy 94, 1077-1093, 2017 | 29 | 2017 |
Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia MA Esmaili, A Kazemi, M Faranoush, H Mellstedt, F Zaker, M Safa, ... Iranian journal of basic medical sciences 23 (6), 800, 2020 | 27 | 2020 |
Wilm’s tumor: epidemiology and survival M Faranoush, GR Bahoush, A Mehrvar, S Hejazi, P Vossough, ... Research Journal of Biological Sciences 4 (1), 86-9, 2009 | 27 | 2009 |
Immunophenotypic subtyping of leukemic cells from Iranian patients with acute lymphoblastic leukaemia: association to disease outcome H Asgarian Omran, M Shabani, T Shahrestani, A Sarafnejad, ... Iranian Journal of Immunology 4 (1), 15-25, 2007 | 27 | 2007 |
Consequences of delayed diagnosis in treatment of retinoblastoma M Faranoush, AAH Asl, A Mehrvar, N Mehrvar, R Zangooei, E Abadi, ... Iranian journal of pediatrics 24 (4), 381, 2014 | 26 | 2014 |
Childhood central nervous system tumors at MAHAK’s Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran A Mehrvar, M Faranoush, AA Hedayati Asl, M Tashvighi, MA Fazeli, ... Child's Nervous System 30, 491-496, 2014 | 26 | 2014 |
Long-term follow-up of ninety eight Iranian patients with primary immune deficiency in a single tertiary centre Allergol Immunopathol (Madr), 2016 | 24* | 2016 |
A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency M Faranoush, H Abolghasemi, G Toogeh, M Karimi, P Eshghi, ... Clinical and Applied Thrombosis/Hemostasis 21 (8), 724-728, 2015 | 24 | 2015 |
A comparison of efficacy between recombinant activated factor VII (Aryoseven) and Novoseven in patients with hereditary FVIII deficiency with inhibitor M Faranoush, H Abolghasemi, F Mahboudi, G Toogeh, M Karimi, ... Clinical and Applied Thrombosis/Hemostasis 22 (2), 184-190, 2016 | 22 | 2016 |
Factors associated with cord blood IgE levels M Nabavi, R Ghorbani, AM Asadi, M Faranoush Asian Pacific Journal of Allergy and Immunology 31 (2), 157, 2013 | 22 | 2013 |
A double-blind, randomized comparison study between Zytux™ vs MabThera® in treatment of CLL with FCR regimen: non-inferiority clinical trial G Toogeh, M Faranoush, SM Razavi, H Jalaeikhoo, A Allahyari, ... International Journal of Hematology-Oncology and Stem Cell Research 12 (2), 84, 2018 | 21 | 2018 |